磷酸西格列汀治疗2型糖尿病35例临床分析

A clinical analysis of treating 35 cases of type 2 diabetes mellitus with sigmatidine phosphate

目的:探究磷酸西格列汀治疗2型糖尿病患者的临床疗效情况。方法:选取35例在我院2016年1月-2016年6月接受治疗的2型糖尿病患者做研究,随机分为对照组、观察组,对照组17例患者,观察组18例患者。对照组给予胰岛素注射治疗,观察组给予磷酸西格列汀治疗。对比两组患者的临床疗效、胆固醇、糖化血红蛋白和C肽的情况。结果:观察组患者总有效率为94.44%,胆固醇及糖化血红蛋白的恢复状况较好,C肽的活性更大,观察组优越性高(P<0.05)。结论:磷酸西格列汀对于2型糖尿病的临床治疗效果显著。

Objective:To investigate the clinical efficacy of sigmatidine phosphate on type2diabetes mellitus.Methods:35patients were randomly divided into control group(n=17)and observation group(n=18).Control group took insulin injection therapy,observation group took sigmatidine phosphate treatment.Results:The total effective rate was94.44%in the observation group,the recoveryof cholesterol and glycated hemoglobin was better,the activity of C peptide was higher,and the superiority of the observation group washigher(P<0.05).Conclusion:Sigmatadine phosphate has a significant effect on type2diabetes mellitus.